Loading...
Loading...
Browse all stories on DeepNewz
VisitMajor Pharma Adoption of OpenCRISPR-1 by 2024 End?
Yes • 50%
No • 50%
Corporate press releases, major biotechnology news outlets
ProfluentBio Launches OpenCRISPR-1, First AI-Designed Open-Source Gene Editor
Apr 23, 2024, 01:49 AM
ProfluentBio has announced the successful deployment of the first ever AI-designed gene editor, OpenCRISPR-1, marking a significant advancement in genetic engineering. This innovative tool, developed using ProfluentBio's large language models, consists of a Cas9-like protein and guide RNA. The company has decided to freely release the molecules under the OpenCRISPR initiative, aiming to democratize access to cutting-edge gene editing capabilities and accelerate the development of personalized medicine. The release of OpenCRISPR-1 is expected to revolutionize the field of biomedicine by enabling more widespread and ethical use of CRISPR technologies. Coverage of this development has been provided by @nytimes, with further details available in an article by @cademetz.
View original story
Therapeutic applications • 25%
Research tools • 25%
Diagnostic tools • 25%
Personalized medicine • 25%
North America • 25%
Europe • 25%
Asia-Pacific • 25%
Rest of World • 25%
Moderate (11-30 institutions) • 25%
Low (0-10 institutions) • 25%
Very High (over 50 institutions) • 25%
High (31-50 institutions) • 25%
Veterinary • 25%
Biomedicine • 25%
Biotechnology research • 25%
Agriculture • 25%